BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9973249)

  • 1. Role of the third intracellular loop for the activation of gonadotropin receptors.
    Schulz A; Schöneberg T; Paschke R; Schultz G; Gudermann T
    Mol Endocrinol; 1999 Feb; 13(2):181-90. PubMed ID: 9973249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A study on the role of the transmembrane V to VI regions of the human luteinizing hormone receptor in its constitutive activation].
    Kudo M
    Hokkaido Igaku Zasshi; 1999 Jan; 74(1):53-65. PubMed ID: 10331060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural differences in the hinge region of the glycoprotein hormone receptors: evidence from the sulfated tyrosine residues.
    Bonomi M; Busnelli M; Persani L; Vassart G; Costagliola S
    Mol Endocrinol; 2006 Dec; 20(12):3351-63. PubMed ID: 16901970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
    Alvarez CA; Narayan P; Huang J; Puett D
    Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mutation of the luteinizing hormone receptor gene causing male gonadotropin-independent precocious puberty.
    Latronico AC; Anasti J; Arnhold IJ; Mendonça BB; Domenice S; Albano MC; Zachman K; Wajchenberg BL; Tsigos C
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2490-4. PubMed ID: 7629248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop.
    Kudo M; Osuga Y; Kobilka BK; Hsueh AJ
    J Biol Chem; 1996 Sep; 271(37):22470-8. PubMed ID: 8798412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor.
    Yano K; Kohn LD; Saji M; Okuno A; Cutler GB
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2586-91. PubMed ID: 9253338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The C-terminal third of the human luteinizing hormone (LH) receptor is important for inositol phosphate release: analysis using chimeric human LH/follicle-stimulating hormone receptors.
    Hirsch B; Kudo M; Naro F; Conti M; Hsueh AJ
    Mol Endocrinol; 1996 Sep; 10(9):1127-37. PubMed ID: 8885247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anionic residue at position 564 is important for maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor.
    Kosugi S; Mori T; Shenker A
    Mol Pharmacol; 1998 May; 53(5):894-901. PubMed ID: 9584216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive charges in a putative amphiphilic helix in the carboxyl-terminal region of the third intracellular loop of the luteinizing hormone/chorionic gonadotropin receptor are not required for hormone-stimulated cAMP production but are necessary for expression of the receptor at the plasma membrane.
    Wang H; Jaquette J; Collison K; Segaloff DL
    Mol Endocrinol; 1993 Nov; 7(11):1437-44. PubMed ID: 8114758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource.
    Kleinau G; Brehm M; Wiedemann U; Labudde D; Leser U; Krause G
    Mol Endocrinol; 2007 Feb; 21(2):574-80. PubMed ID: 17110401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man.
    Gromoll J; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1367-70. PubMed ID: 8636335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional role of transmembrane helix 7 in the activation of the heptahelical lutropin receptor.
    Angelova K; Narayan P; Simon JP; Puett D
    Mol Endocrinol; 2000 Apr; 14(4):459-71. PubMed ID: 10770485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite contribution of two ligand-selective determinants in the N-terminal hormone-binding exodomain of human gonadotropin receptors.
    Vischer HF; Granneman JC; Bogerd J
    Mol Endocrinol; 2003 Oct; 17(10):1972-81. PubMed ID: 12869592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor.
    Wang Z; Wang H; Ascoli M
    Mol Endocrinol; 1993 Jan; 7(1):85-93. PubMed ID: 8383288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular retention of mutant gonadotropin receptors results in loss of hormone binding activity of the follitropin receptor but not of the lutropin/choriogonadotropin receptor.
    Rozzell TG; Wang H; Liu X; Segaloff DL
    Mol Endocrinol; 1995 Dec; 9(12):1727-36. PubMed ID: 8614409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S; Okajima F; Ban T; Hidaka A; Shenker A; Kohn LD
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletions in the third intracellular loop of the thyrotropin receptor. A new mechanism for constitutive activation.
    Wonerow P; Schöneberg T; Schultz G; Gudermann T; Paschke R
    J Biol Chem; 1998 Apr; 273(14):7900-5. PubMed ID: 9525885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling.
    Bhowmick N; Huang J; Puett D; Isaacs NW; Lapthorn AJ
    Mol Endocrinol; 1996 Sep; 10(9):1147-59. PubMed ID: 8885249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of substitutions of a highly conserved leucine in transmembrane helix III of the human lutropin/choriogonadotropin receptor with respect to constitutive activation and hormone responsiveness.
    Shinozaki H; Fanelli F; Liu X; Jaquette J; Nakamura K; Segaloff DL
    Mol Endocrinol; 2001 Jun; 15(6):972-84. PubMed ID: 11376115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.